Table 1.
Demographic characteristics of the control and congestive heart failure (CHF) groups.
| Control (n = 15) | CHF (n = 35) | p value | |
|---|---|---|---|
| Age (years) | 8.0 [6.9–10.0] | 10.2 [7.9–10.9] | 0.141 |
| Sex | 0.462 | ||
| Female (%) | 7 (46.7%) | 10 (28.6%) | |
| Neutered: entire | 7:0 | 10:0 | |
| Male (%) | 8 (53.3%) | 25 (71.4%) | |
| Neutered: entire | 5:3 | 15:10 | |
| Breeds (%) | 0.106 | ||
| Small breeds | 4 (26.7%) | 18 (51.4%) | |
| Large breeds | 11 (73.3%) | 17 (48.6%) | |
| Body weight (kg) | 20.3 [12.1–33.0] | 12.0 [7.3–42.5] | 0.352 |
| BCS (/9) | 0.005 | ||
| 1/9 | 0 | 1 (2.9%) | |
| 2/9 | 0 | 4 (11.4%) | |
| 3/9 | 0 | 8 (22.9%) | |
| 4/9 | 3 (20.0%) | 4 (40.0%) | |
| 5/9 | 6 (40.0%) | 6 (17.1%) | |
| 6/9 | 6 (40.0%) | 2 (5.7%) | |
| Muscle conditiona | < 0.001 | ||
| Normal | 15 (100%) | 8 (22.8%) | |
| Mild | 0 | 11 (31.4%) | |
| Moderate | 0 | 9 (25.7%) | |
| Severe | 0 | 6 (17.1%) | |
| Diet | |||
| Dog food | 15 (100%) | 33 (94.3%) | 1.000 |
| Human food | 5 (33.3%) | 23 (65.7%) | 0.061 |
| Appetite | < 0.001 | ||
| Normal | 15 (100%) | 13 (37.1%) | |
| Reduced | 0 | 22 (62.9%) | |
| Duration of CHF (weeks) | – | 6.0 [3.0–28.0] | – |
| Medication | |||
| Diuretic dose (mg/kg/day) | – | 4.4 [3.4–7.1] | – |
| Furosemide | 0 | 28 (80.0%) | – |
| Torsemide | 0 | 4 (11.4%) | – |
| Pimobendan | 0 | 33 (94.3%) | – |
| Benazepril | 0 | 25 (71.4%) | – |
| Spironolactone | 0 | 23 (65.7%) | – |
| Fish oil | 0 | 4 (11.4%) | – |
| Diltiazem/digoxin | 0 | 9 (25.7%) | – |
aOne dog in the CHF group was missing a muscle condition score. The results are displayed as median [25th, 75th percentiles] as they were non-normally distributed. Statistical significance (p < 0.05) is marked bold.